Gedeon Richter PLC
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGEDF research report →
About the company
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases.
- CEO
- Gábor Orbán
- IPO
- 2013
- Employees
- 11,955
- HQ
- Budapest, BC, HU
Price Chart
- Market Cap
- $7.27B
- P/E
- 9.71
- P/S
- 2.41
- P/B
- 1.53
- EV/EBITDA
- 5.70
- Div Yield
- 5.38%
- Gross Margin
- 67.55%
- Op Margin
- 33.69%
- Net Margin
- 24.80%
- ROE
- 16.73%
- ROIC
- 16.00%
- Revenue
- $923.40B · 7.68%
- Net Income
- $230.94B · -3.47%
- EPS
- $1263.79 · -3.31%
- Op Income
- $321.78B
- FCF YoY
- 15.12%
- 52W High
- $45.28
- 52W Low
- $27.17
- 50D MA
- $40.13
- 200D MA
- $33.64
- Beta
- 0.31
- Avg Volume
- 1.14K
Get TickerSpark's AI analysis on RGEDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RGEDF coverage
Recent articles, reports, and earnings notes.
No research on RGEDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RGEDF report →Similar companies
Peers in the same neighborhood.